| Merck (Schweiz) AG - Rebif 8.8 und 22, Injektionslösung in Fertigspritzen | | 54810 | | 04 | | Rebif 8.8 und 22 | | Injektionslösung in Fertigspritzen | | L03AB07 | | Interferon Beta-1a | | 10.10.2008 | | |
| | Composition | | I) 8.8 mcg/0.2 ml: interferonum beta-1a ADNr 8.8 µg corresp. 2.4 Mio U.I., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg.
II) 22 mcg/0.5 ml: interferonum beta-1a ADNr 22 µg corresp. 6 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. | | Packungsbestandteile | | I | | | Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 8.8µg / 0.2ml |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Alcohol Benzylicus | 1mg / 0.2ml | | Mannitol | | | Methionine | | | Sodium Acetate Trihydrate | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
| II | | | Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22µg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Alcohol Benzylicus | 2.5mg / 0.5ml | | Mannitol | | | Methionine | | | Sodium Acetate Trihydrate | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 060 | 6 Kombipackung(en) | 599.44 | 668.35 | B | SL | Yes |
|
|
